Open AccessThe Looming Success in Cancer Vaccination
Author(s) -
Shafkat Shamim Rahman
Publication year - 2019
Publication title -
advanced emergency medicine
Language(s) - English
Resource type - Journals
ISSN - 2315-456X
DOI - 10.18686/aem.v8.137
Subject(s) - clinical trial , vaccination , medicine , vision , human papillomavirus , hepatitis b virus , cancer , looming , virology , family medicine , virus , psychology , sociology , anthropology , cognitive psychology
Cancer vaccination projects are on trial worldwide and the results are far-off being a remarkable success. Albeit, thousands of clinical trials are taking place, only a several of those are producing a significant result to increase the survival rate of the patients. Four vaccines (Human papillomavirus - HPV vaccines, Hepatitis B virus - HBV vaccines, Sipuleucel-T and Oncophage) are approved for market in the United States and Russia so far. Most of the prototype vaccines are yielding at phase III clinical trials after being successful at phase I and II. Apparently, new visions and approaches are required to guide these projects to harvest better results.